The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 08, 2019
Filed:
Jul. 28, 2016
Applicant:
Nymox Corporation, Nassau, New Providence, BS;
Inventor:
Paul Averback, Nassau, BS;
Assignee:
NYMOX CORPORATION, Nassau, BS;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/10 (2006.01); A61K 38/08 (2006.01); A61K 38/16 (2006.01); A61K 31/7088 (2006.01); A61K 39/00 (2006.01); A61K 48/00 (2006.01); C07K 7/08 (2006.01); C07K 7/06 (2006.01); C07K 14/435 (2006.01); C07K 14/47 (2006.01); C07K 16/30 (2006.01); C07K 19/00 (2006.01); C07K 16/44 (2006.01); C07K 4/00 (2006.01); A61K 31/517 (2006.01);
U.S. Cl.
CPC ...
A61K 38/10 (2013.01); A61K 31/517 (2013.01);
Abstract
Methods of preventing or reducing the incidence of acute urinary retention in mammals susceptible to developing acute urinary retention, and methods of reducing the incidence of clinically detected prostate cancer, using compositions containing compounds based on small peptides and a pharmaceutically acceptable carrier, are described. The methods include, but are not limited to, administering the compounds intramuscularly, orally, intravenously, intraprostatically, intrathecally, intratumorally, intranasally, topically, transdermally, etc., either alone or conjugated to a carrier to a mammal in need thereof.